Conservative treatment of peripheral arterial occlusive disease

被引：0

作者：

Boehner, H. ^{[1
,2
]}

Klemp, U.

Pourhassan, S. ^{[3
]}

Pillny, M.

Aleksic, M. ^{[4
]}

Nowak, T.

Balzer, K. M. ^{[5
]}

Geier, B. ^{[6
]}

Kroeger, K. ^{[7
]}

机构：

[1] Katholisches Krankenhaus Dortmund W, Klin Viszeral & Gefasschirurg, D-44379 Dortmund, Germany

[2] St Rochus Krankenhaus Castrop Rauxel, D-44379 Dortmund, Germany

[3] Gefasschirurg Gemeinschaftspraxis, Oberhausen, Germany

[4] Univ Witten Herdecke, Krankenhaus Koln Merheim, Klin Gefasschirurg, Cologne, Germany

[5] Univ Dusseldorf, Klin Gefasschirurg & Nierentransplantat, D-40225 Dusseldorf, Germany

[6] Krankenhaus Bethanien, Klin Gefasschirurg, Moers, Germany

[7] HELIOS Klinikum Krefeld, Klin Gefasschirurg, Krefeld, Germany

来源：

GEFASSCHIRURGIE | 2012年 / 17卷 / 03期

关键词：

Peripheral arterial occlusive disease (PAOD); Secondary prevention; Statin therapy; Walking exercise; Cilostazol; INTERMITTENT CLAUDICATION; SKELETAL-MUSCLE; EXERCISE; THERAPY; NAFTIDROFURYL; CILOSTAZOL; SURGERY;

D O I：

10.1007/s00772-012-1004-9

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Peripheral arterial occlusive disease (PAOD) is a frequent manifestation of generalized atherosclerosis which leads to reduced quality of life through reduced mobility and might result in loss of limbs in cases of progression especially in diabetics. The aims of conservative therapy are symptomatic relief through pharmacological and other treatment and reduction of atherosclerotic risk factors in order to prevent progression of the underlying atherosclerosis and therefore avoiding amputation as well as cardiac and cerebral events.

引用

页码：219 / 224

页数：6

共 25 条

[1] The role of cilostazol for peripheral arterial disease [J].

Amendt, K. ;

Hsu, E. ;

Gomer, M. ;

Ruemenapf, G. .

GEFASSCHIRURGIE, 2008, 13 (03) :171-+

[2]

Amendt K, 2007, GEFASSCHIRURGIE, V12, P63, DOI 10.1007/s00772-006-0509-5

[3]

Anand S, 2007, NEW ENGL J MED, V357, P217

[4]

[Anonymous], 2011, 153 BANZ, P3508

[5]

[Anonymous], 2000, COCHRANE DB SYST REV

[6]

Böhner H, 2008, GEFASSCHIRURGIE, V13, P158, DOI 10.1007/s00772-008-0593-9

[7] European multicenter study on propionyl-L-carnitine in intermittent claudication [J].

Brevetti, G ;

Diehm, C ;

Lambert, D .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (05) :1618-1624

[8]

Deutsche Gesellschaft fur Angiologie, 2009, LEITL DIAGN THER PER

[9]

Gardner AW, 2008, J CARDIOPULM REHABIL, V28, P349, DOI 10.1097/HCR.0b013e31818c3b96

[10] EXERCISE REHABILITATION PROGRAMS FOR THE TREATMENT OF CLAUDICATION PAIN - A METAANALYSIS [J].

GARDNER, AW ;

POEHLMAN, ET .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (12) :975-980

← 1 2 3 →